-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2014 to Q2 2023.
- Eagle Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 13.2M shares, a 2.48% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13.1M shares, a 0.11% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 13.1M shares, a 5.23% decline from 2020.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 13.8M shares, a 2.6% decline from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)